Skip to main content

USANA HEALTH SCIENCES INC

For the period ended Dec 28, 2024. Filed Mar 12, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 12, 2025

USNA$13.10-5.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Comprehensive Income

Fiscal Year
202420232022
Net sales$854,503$921,010$998,601
Cost of sales161,212176,693193,890
Gross profit693,291744,317804,711
Operating expenses:
Associate incentives363,699394,257434,793
Selling, general and administrative263,268256,989262,304
Total operating expenses626,967651,246697,097
Earnings from operations66,32493,071107,614
Other income (expense):
Interest income11,3199,6373,789
Interest expense(281)(262)(192)
Other, net(1,011)7(2,590)
Other income (expense), net10,0279,3821,007
Earnings before income taxes76,351102,453108,621
Income taxes34,29138,66539,271
Net earnings42,06063,78869,350
Less: Net earnings attributable to redeemable noncontrolling interest30——
Net earnings attributable to USANA$42,030$63,788$69,350
Earnings per common share attributable to USANA
Basic$2.20$3.31$3.60
Diluted$2.19$3.30$3.59
Weighted average common shares outstanding
Basic19,10319,25019,254
Diluted19,16219,34519,310
Comprehensive income:
Net earnings$42,060$63,788$69,350
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment(9,409)(1,298)(15,126)
Tax benefit (expense) related to foreign currency translation adjustment4343901,881
Other comprehensive income (loss), net of tax(8,975)(908)(13,245)
Comprehensive income33,08562,88056,105
Less: comprehensive income attributable to redeemable noncontrolling interest30——
Comprehensive income attributable to USANA$33,055$62,880$56,105
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.